The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis
Jie Fu,1 Lilei Peng,2 Xiaogang Li1 1Department of Neurology, 2Department of Neurosurgery, The Affiliated Hospital of Luzhou Medical College, Luzhou, People’s Republic of China Objective: Vortioxetine is a novel antidepressant approved for the treatment of major depressive disorder by the...
Guardado en:
Autores principales: | Fu J, Peng LL, Li XG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45ffe0a13c884ef29dfe92ae63183fce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
por: Li G, et al.
Publicado: (2016) -
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
por: McIntyre RS, et al.
Publicado: (2021) -
Efficacy of serotonin receptor agonists in the treatment of functional dyspepsia: a meta-analysis
por: Man Jin, et al.
Publicado: (2018) -
Efficacy and safety of medical treatment of chronic anxiety disorders in diabetic patients
por: Elena Georgievna Starostina, et al.
Publicado: (2010) -
Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
por: Huang Q, et al.
Publicado: (2016)